Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Depreciation and Depletion (2016 - 2020)

International Stem Cell (ISCO) has disclosed Depreciation and Depletion for 10 consecutive years, with $41000.0 as the latest value for Q1 2020.

  • On a quarterly basis, Depreciation and Depletion rose 10.81% to $41000.0 in Q1 2020 year-over-year; TTM through Mar 2020 was $167000.0, a 0.0% change, with the full-year FY2015 number at $373000.0, down 5.81% from a year prior.
  • Depreciation and Depletion was $41000.0 for Q1 2020 at International Stem Cell, up from $37000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $57000.0 in Q1 2016 to a low of $37000.0 in Q1 2019.
  • A 5-year average of $46454.5 and a median of $48000.0 in 2017 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: tumbled 48.42% in 2016, then grew 10.81% in 2020.
  • International Stem Cell's Depreciation and Depletion stood at $51000.0 in 2016, then fell by 5.88% to $48000.0 in 2017, then dropped by 6.25% to $45000.0 in 2018, then decreased by 17.78% to $37000.0 in 2019, then increased by 10.81% to $41000.0 in 2020.
  • Per Business Quant, the three most recent readings for ISCO's Depreciation and Depletion are $41000.0 (Q1 2020), $37000.0 (Q1 2019), and $45000.0 (Q3 2018).